155 related articles for article (PubMed ID: 32113189)
41. Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies.
Geerlings SE; Beerepoot MA; Prins JM
Infect Dis Clin North Am; 2014 Mar; 28(1):135-47. PubMed ID: 24484580
[TBL] [Abstract][Full Text] [Related]
42. Bacterial resistance in urinary tract infections: how to stem the tide.
Fluit AC; Schmitz FJ
Expert Opin Pharmacother; 2001 May; 2(5):813-8. PubMed ID: 11336624
[TBL] [Abstract][Full Text] [Related]
43. Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis.
Nateghian AR; Robinson JL; Mohandessi S; Hooman N
J Infect Public Health; 2009; 2(3):147-52. PubMed ID: 20701875
[TBL] [Abstract][Full Text] [Related]
44. Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model.
Gordon J; Darlington O; McEwan P; Lumley M; Taie A; Hicks M; Charbonneau C; Blake A; Hawkins N; Goldenberg S; Otter J; Wilcox M
Pharmacoeconomics; 2020 Aug; 38(8):857-869. PubMed ID: 32249396
[TBL] [Abstract][Full Text] [Related]
45. Re-examining advice to complete antibiotic courses: a qualitative study with clinicians and patients.
Borek AJ; Edwards G; Santillo M; Wanat M; Glogowska M; Butler CC; Walker AS; Hayward G; Tonkin-Crine S
BJGP Open; 2023 Jun; 7(2):. PubMed ID: 36720563
[TBL] [Abstract][Full Text] [Related]
46. Assessment and treatment of recurrent urinary tract infections in women: development of a questionnaire based on a qualitative study of patient expectations in secondary care.
Pat JJ; Aart TVD; Steffens MG; Witte LPW; Blanker MH
BMC Urol; 2020 Dec; 20(1):190. PubMed ID: 33267816
[TBL] [Abstract][Full Text] [Related]
47. The challenges of treating women with recurrent urinary tract infections in primary care: a qualitative study of GPs' experiences of conventional management and their attitudes towards possible herbal options.
Flower A; Winters D; Bishop FL; Lewith G
Prim Health Care Res Dev; 2015 Nov; 16(6):597-606. PubMed ID: 25772398
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial Agents and Urinary Tract Infections.
Issakhanian L; Behzadi P
Curr Pharm Des; 2019; 25(12):1409-1423. PubMed ID: 31218955
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.
De Waele JJ; Akova M; Antonelli M; Canton R; Carlet J; De Backer D; Dimopoulos G; Garnacho-Montero J; Kesecioglu J; Lipman J; Mer M; Paiva JA; Poljak M; Roberts JA; Rodriguez Bano J; Timsit JF; Zahar JR; Bassetti M
Intensive Care Med; 2018 Feb; 44(2):189-196. PubMed ID: 29288367
[TBL] [Abstract][Full Text] [Related]
50. Reaching the End of the Line: Urinary Tract Infections.
Tamadonfar KO; Omattage NS; Spaulding CN; Hultgren SJ
Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172909
[TBL] [Abstract][Full Text] [Related]
51. Diet as a risk factor for antimicrobial resistance in community-acquired urinary tract infections in a middle-aged and elderly population: a case-control study.
Mulder M; Kiefte-de Jong JC; Goessens WHF; de Visser H; Ikram MA; Verbon A; Stricker BH
Clin Microbiol Infect; 2019 May; 25(5):613-619. PubMed ID: 30099137
[TBL] [Abstract][Full Text] [Related]
52. Urinary Tract Infection in Children: Management in the Era of Antibiotic Resistance-A Pediatric Urologist's View.
Kutasy B; Coyle D; Fossum M
Eur Urol Focus; 2017 Apr; 3(2-3):207-211. PubMed ID: 28965960
[TBL] [Abstract][Full Text] [Related]
53. Canadian physicians' knowledge and counseling practices related to antibiotic use and antimicrobial resistance: Two-cycle national survey.
Smith CR; Pogany L; Foley S; Wu J; Timmerman K; Gale-Rowe M; Demers A
Can Fam Physician; 2017 Dec; 63(12):e526-e535. PubMed ID: 29237649
[TBL] [Abstract][Full Text] [Related]
54. Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study.
Mulder M; Baan E; Verbon A; Stricker B; Verhamme K
BMJ Open; 2019 May; 9(5):e027221. PubMed ID: 31110099
[TBL] [Abstract][Full Text] [Related]
55. Older women's experiences of suffering from urinary tract infections.
Eriksson I; Olofsson B; Gustafson Y; Fagerström L
J Clin Nurs; 2014 May; 23(9-10):1385-94. PubMed ID: 24372625
[TBL] [Abstract][Full Text] [Related]
56. Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
Martínez EP; van Rosmalen J; Bustillos R; Natsch S; Mouton JW; Verbon A
J Antimicrob Chemother; 2020 Aug; 75(8):2314-2325. PubMed ID: 32417922
[TBL] [Abstract][Full Text] [Related]
57. Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model.
Wozniak TM; Bailey EJ; Graves N
Infect Control Hosp Epidemiol; 2019 Mar; 40(3):320-327. PubMed ID: 30887942
[TBL] [Abstract][Full Text] [Related]
58. Exploring the potential for children to act on antimicrobial resistance in Nepal: Valuable insights from secondary analysis of qualitative data.
Mitchell J; Cooke P; Arjyal A; Baral S; Jones N; Garbovan L; King R
PLoS One; 2023; 18(6):e0285882. PubMed ID: 37267313
[TBL] [Abstract][Full Text] [Related]
59. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance.
Pobiega M; Maciag J; Pomorska-Wesolowska M; Chmielarczyk A; Romaniszyn D; Ziolkowski G; Heczko PB; Wojkowska-Mach J; Bulanda M
J Pediatr Urol; 2016 Feb; 12(1):36.e1-6. PubMed ID: 26320394
[TBL] [Abstract][Full Text] [Related]
60. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
